@CMOfficeUP We need an enquiry on EC members held on 15th April 2026 for Healthcare vertical as why due to no valid reasoning they have unrecommended the Startup. @CMOfficeUP we request you to kindly take action. My team has been very much discouraged due to this.
I am very much disappointed by the @CMOfficeUP@myogioffice as they have not addressed to the complaint of a startup of their own state yet. This is really grieving and shocking that the work of startups are not taken seriously by govt. Of Uttar Pradesh.
We are dedicated to uplift lives of patients of Uttar Pradesh since last five years but the @CMOfficeUP is not even considering our complaint that is really discouraging to the other new startups in UP as well.
My startup @DiassenceH has been invited for Forbes India feature recently and here the @UPStartuppolicy thinks that the startup is not working enough to receive the grant. They dropped us in between for the support. Pls help @myogioffice@CMOfficeUP
I request the Govt of UP and honโble CM to resolve our grievance. As a woman founder from UP who is working for last 10 years in healthcare and working towards uplifting lives of dialysis patients this is something which has disappointed me very deeply.
Unpopular opinion:
Dialysis doesnโt need more machines.
It needs more intelligence.
Weโve optimized hardware for years.
But ignored the goldmine โ patient data.
AI can:
โข Predict hypotension
โข Optimize fluid removal
โข Personalize treatment
Dialysis is keeping millions alive.
But are we making it smarter?
Every session generates critical data
BP fluctuations, fluid shifts, complications.
Most of it? Underused.
AI can change that.
From โjust surviving sessionsโ ๏ฟฝ๏ฟฝ to predicting risks before they happen.
With total five years of journey in kidney care and dialysis , we have come up with the new vision and a new phase of @diassenceh . Excited for the years ahead in bringing revolution to kidney care.
High time that the government run a special health scheme for the diabetes epidemic. The private insurers come across high cost coverage in cases of insulin dependent people and if other complications are present too + the unfavourable taxation.